Biofilms are estimated to be responsible for 80% of all human infections and cost industry, cities and hospitals in excess of $500 billion each year.

Biofilms are formed when bacteria and/or fungi adhere to surfaces and excrete a glue-like substance that acts as an anchor and provides protection from the environment. Biofilm formation can make bacteria up to 1000 times more resistant to antibiotics, antimicrobial agents, disinfectants and the host immune system and are acknowledged to be one of the main contributors to the “antibiotic resistance crisis”.

Kane Biotech focuses on novel products that prevent and disperse bacterial biofilms with 81 patents and patents pending. Kane Biotech is THE Biofilm Company – creating smarter ways to fight bacteria. Kane is leading the advancement of technologies and products that break up biofilms and destroy bacteria.

Kane Biotech is a Canadian-based technology company engaged in the development and commercialization of products that prevent and remove microbial biofilms. The Company was formed in 2001 to study the genetic mechanisms of biofilm formation, which has led to the discovery of novel compounds that inhibit or disrupt biofilms.